Dysfunctional adaptive immunity during parasitic infections

Current Immunology Reviews

Volumn 9, Issue 3, 2013, Pages 179-189

  Zander, Ryan A ^a,b   Butler, Noah S ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

B cell; Chronic infection; Exhaustion; Helminth; Parasite; Protozoan; T cell

Indexed keywords

ADAPTIVE IMMUNITY; B LYMPHOCYTE; CLINICAL STUDY; EXPERIMENTAL MODEL; HOST; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; IMMUNOTHERAPY; NONHUMAN; PARASITE; PARASITOSIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; VACCINATION;

EID: 84894034904     PISSN: 15733955     EISSN: 1875631X     Source Type: Journal    
DOI: 10.2174/1573395509666131126230832     Document Type: Review

References (116)

1. World Health Organization (WHO). World Malaria Report 2012. 2012; Available from: http://www.who.int/malaria/publications/world_malaria_report_2012/en/
2. Tran TM, Li S, Doumbo S, et al. An Intensive Longitudinal Cohort Study of Malian Children and Adults Reveals No Evidence of Acquired Immunity to Plasmodium falciparum Infection. Clin Infect Dis 2013; 57(1): 40-7.
3. Okwor I, Uzonna J. Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies. Immunol Res 2008; 41(2): 123-36.
4. Aikpon R, Agossa F, Osse R, et al. Bendiocarb resistance in Anopheles gambiae s.l. populations from Atacora department in Benin, West Africa: a threat for malaria vector control. Parasit Vectors 2013; 6: 192.
5. Miller LH, Ackerman HC, Su XZ, Wellems TE. Malaria biology and disease pathogenesis: insights for new treatments. Nat Med 2013; 19(2): 156-67.
6. Kyes S, Horrocks P, Newbold C. Antigenic variation at the infected red cell surface in malaria. Ann Rev Microbiol 2001; 55: 673-707.
7. Turner L, Lavstsen T, Berger SS, et al. Severe malaria is associated with parasite binding to endothelial protein C receptor. Nature 2013; 498(7455): 502-5.
8. Bannard O, Kraman M, Fearon D. Pathways of memory CD8+ Tcell development. Eur J Immunol 2009; 39(8): 2083-7.
9. Duffy PE, Sahu T, Akue A, Milman N, Anderson C. Preerythrocytic malaria vaccines: identifying the targets. Expert Rev Vaccines 2012; 11(10): 1261-80.
10. Singh B, Sundar S. Leishmaniasis: vaccine candidates and perspectives. Vaccine 2012; 30(26): 3834-42.
11. Jordan KA, Hunter CA. Regulation of CD8+ T cell responses to infection with parasitic protozoa. Exp Parasitol 2010; 126(3): 318-25.
12. McConkey GA, Martin HL, Bristow GC, Webster JP. Toxoplasma gondii infection and behaviour -location, location, location? J Exp Biol 2013; 216(Pt 1): 113-9.
13. McCall LI, Zhang WW, Matlashewski G. Determinants for the development of visceral leishmaniasis disease. PLoS pathogens 2013; 9(1): e1003053.
14. Muller I, Kropf P, Etges RJ, Louis JA. Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cells. Infect Immun 1993; 61(9): 3730-8.
15. Titus RG, Milon G, Marchal G, Vassalli P, Cerottini JC, Louis JA. Involvement of specific Lyt-2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis. Eur J Immunol 1987; 17(10): 1429-33.
16. Colmenares M, Kima PE, Samoff E, Soong L, McMahon-Pratt D. Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection. Infect Immun 2003; 71(6): 3172-82.
17. Overstreet MG, Chen YC, Cockburn IA, Tse SW, Zavala F. CD4 T cells modulate expansion and survival but not functional properties of effector and memory CD8+ T cells induced by malaria sporozoites. PloS one 2011; 6(1): e15948.
18. Padilla A, Xu D, Martin D, Tarleton R. Limited role for CD4+ Tcell help in the initial priming of Trypanosoma cruzi-specific CD8+ T cells. Infect Immun 2007; 75(1): 231-5.
19. Frevert U, Moreno A, Calvo-Calle JM, Klotz C, Nardin E. Imaging effector functions of human cytotoxic CD4+ T cells specific for Plasmodium falciparum circumsporozoite protein. Int J Parasitol 2009; 39(1): 119-32.
20. Keesen TS, Gomes JA, Fares RC, et al. Characterization of CD4(+) cytotoxic lymphocytes and apoptosis markers induced by Trypanossoma cruzi infection. Scand J Immunol 2012; 76(3): 311-9.
21. Purner MB, Berens RL, Nash PB, et al. CD4-mediated and CD8-mediated cytotoxic and proliferative immune responses to Toxoplasma gondii in seropositive humans. Infect Immun 1996; 64(10): 4330-8.
22. Baird JK, Jones TR, Danudirgo EW, et al. Age-dependent acquired protection against Plasmodium falciparum in people having two years exposure to hyperendemic malaria. Am J Trop Med Hyg 1991; 45(1): 65-76.
23. Gupta S, Snow RW, Donnelly CA, Marsh K, Newbold C. Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat Med 1999; 5(3): 340-3.
24. Cohen S, Mc GI, Carrington S. Gamma-globulin and acquired immunity to human malaria. Nature 1961; 192: 733-7.
25. Radwanska M, Guirnalda P, De Trez C, Ryffel B, Black S, Magez S. Trypanosomiasis-induced B cell apoptosis results in loss of protective anti-parasite antibody responses and abolishment of vaccine-induced memory responses. PLoS Pathogens 2008; 4(5): e1000078.
26. Crotty S. Follicular helper CD4 T cells (TFH). Ann Review Immunol 2011; 29: 621-63.
27. Kang H, Remington JS, Suzuki Y. Decreased resistance of B celldeficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase. J Immunol 2000; 164(5): 2629-34.
28. McCoy KD, Stoel M, Stettler R, et al. Polyclonal and specific antibodies mediate protective immunity against enteric helminth infection. Cell Host Microbe 2008; 4(4): 362-73.
29. Wojciechowski W, Harris DP, Sprague F, et al. Cytokineproducing effector B cells regulate type 2 immunity to H. polygyrus. Immunity 2009; 30(3): 421-33.
30. Johnson LL, Sayles PC. Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice. Infect Immun 2002; 70(1): 185-91.
31. Langhorne J, Cross C, Seixas E, Li C, von der Weid T. A role for B cells in the development of T cell helper function in a malaria infection in mice. Proc Natl Acad Sci USA 1998; 95(4): 1730-4.
32. von der Weid T, Honarvar N, Langhorne J. Gene-targeted mice lacking B cells are unable to eliminate a blood stage malaria infection. J Immunol 1996; 156(7): 2510-6.
33. Grun JL, Weidanz WP. Immunity to Plasmodium chabaudi adami in the B-cell-deficient mouse. Nature 1981; 290(5802): 143-5.
34. Thakur A, Pedersen LE, Jungersen G. Immune markers and correlates of protection for vaccine induced immune responses. Vaccine 2012; 30(33): 4907-20.
35. Wherry EJ. T cell exhaustion. Nat Immunol 2011; 12(6): 492-9.
36. Zajac AJ, Blattman JN, Murali-Krishna K, et al. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 1998; 188(12): 2205-13.
37. Gallimore A, Glithero A, Godkin A, et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med 1998; 187(9): 1383-93.
38. Fuller MJ, Zajac AJ. Ablation of CD8 and CD4 T cell responses by high viral loads. J Immunol 2003; 170(1): 477-86.
39. Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 2003; 77(8): 4911-27.
40. Brown KE, Freeman GJ, Wherry EJ, Sharpe AH. Role of PD-1 in regulating acute infections. Curr Opin Immunol 2010; 22(3): 397-401.
41. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 2007; 8(3): 239-45.
42. Rudd CE, Taylor A, Schneider H. CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol Rev 2009; 229(1): 12-26.
43. Shui JW, Steinberg MW, Kronenberg M. Regulation of inflammation, autoimmunity, and infection immunity by HVEMBTLA signaling. J leukocyte Biol 2011; 89(4): 517-23.
44. Hafalla JC, Claser C, Couper KN, et al. The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology. PLoS pathogens. 2012; 8(2): e1002504.
45. Wilson EH, Harris TH, Mrass P, et al. Behavior of parasite-specific effector CD8+ T cells in the brain and visualization of a kinesisassociated system of reticular fibers. Immunity 2009; 30(2): 300-11.
46. Bhadra R, Cobb DA, Khan IA. Donor CD8 T cells prevent Toxoplasma de-encystation but fail to rescue exhausted endogenous CD8 population. Infect Immun 2013; 81(9): 3414-25.
47. Bhadra R, Gigley JP, Khan IA. PD-1-mediated attrition of polyfunctional memory CD8+ T cells in chronic toxoplasma infection. J Infect Dis 2012; 206(1): 125-34.
48. Bhadra R, Gigley JP, Weiss LM, Khan IA. Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade. Proc Natl Acad Sci USA 2011; 108(22): 9196-201.
49. Bhadra R, Khan IA. Redefining chronic toxoplasmosis-a T cell exhaustion perspective. PLoS pathogens 2012; 8(10): e1002903.
50. Hernandez-Ruiz J, Salaiza-Suazo N, Carrada G, et al. CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists. PLoS Negl Trop Dis 2010; 4(11): e871.
51. Mou Z, Muleme HM, Liu D, et al. Parasite-derived arginase influences secondary anti-Leishmania immunity by regulating programmed cell death-1-mediated CD4+ T cell exhaustion. J Immunol 2013; 190(7): 3380-9.
52. Leavey JK, Tarleton RL. Cutting edge: dysfunctional CD8+ T cells reside in nonlymphoid tissues during chronic Trypanosoma cruzi infection. J Immunol 2003; 170(5): 2264-8.
53. Arguello RJ, Albareda MC, Alvarez MG, et al. Inhibitory receptors are expressed by Trypanosoma cruzi-specific effector T cells and in hearts of subjects with chronic Chagas disease. PloS one 2012; 7(5): e35966.
54. Albareda MC, Laucella SA, Alvarez MG, et al. Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients. Int Immunol 2006; 18(3): 465-71.
55. Adler G, Steeg C, Pfeffer K, et al. B and T lymphocyte attenuator restricts the protective immune response against experimental malaria. J Immunol 2011; 187(10): 5310-9.
56. Butler NS, Moebius J, Pewe LL, et al. Therapeutic blockade of PDL1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat Immunol 2012; 13(2): 188-95.
57. Illingworth J, Butler NS, Roetynck S, et al. Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion. J Immunol 2013; 190(3): 1038-47.
58. Steel C, Nutman TB. CTLA-4 in filarial infections: implications for a role in diminished T cell reactivity. J Immunol 2003; 170(4): 1930-8.
59. Taylor MD, Harris A, Babayan SA, et al. CTLA-4 and CD4+ CD25+ regulatory T cells inhibit protective immunity to filarial parasites in vivo. J Immunol 2007; 179(7): 4626-34.
60. van der Werf N, Redpath SA, Azuma M, Yagita H, Taylor MD. Th2 cell-intrinsic hypo-responsiveness determines susceptibility to helminth infection. PLoS Pathogens 2013; 9(3): e1003215.
61. Taylor JJ, Krawczyk CM, Mohrs M, Pearce EJ. Th2 cell hyporesponsiveness during chronic murine schistosomiasis is cell intrinsic and linked to GRAIL expression. J Clin Invest 2009; 119(4): 1019-28.
62. McSorley HJ, Maizels RM. Helminth infections and host immune regulation. Clin Microbiol Rev 2012; 25(4): 585-608.
63. Kaufmann DE, Kavanagh DG, Pereyra F, et al. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat Immunol 2007; 8(11): 1246-54.
64. Nakamoto N, Cho H, Shaked A, et al. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathogens 2009; 5(2): e1000313.
65. Cai G, Anumanthan A, Brown JA, Greenfield EA, Zhu B, Freeman GJ. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat Immunol 2008; 9(2): 176-85.
66. Bhadra R, Gigley JP, Khan IA. Cutting edge: CD40-CD40 ligand pathway plays a critical CD8-intrinsic and -extrinsic role during rescue of exhausted CD8 T cells. J Immunol 2011; 187(9): 4421-5.
67. West EE, Jin HT, Rasheed AU, et al. PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells. J Clin Invest 2013; 123(6): 2604-15.
68. Yi JS, Du M, Zajac AJ. A vital role for interleukin-21 in the control of a chronic viral infection. Science 2009; 324(5934): 1572-6.
69. Simone O, Bejarano MT, Pierce SK, et al. TLRs innate immunereceptors and Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) CIDR1alpha-driven human polyclonal B-cell activation. Acta tropica 2011; 119(2-3): 144-50.
70. Donati D, Mok B, Chene A, et al. Increased B cell survival and preferential activation of the memory compartment by a malaria polyclonal B cell activator. J Immunol 2006; 177(5): 3035-44.
71. Cooper PJ, Chico ME, Losonsky G, et al. Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR. J Infect Dis 2000; 182(4): 1199-206.
72. Cooper PJ, Espinel I, Paredes W, Guderian RH, Nutman TB. Impaired tetanus-specific cellular and humoral responses following tetanus vaccination in human onchocerciasis: a possible role for interleukin-10. J Infect Dis 1998; 178(4): 1133-8.
73. Nookala S, Srinivasan S, Kaliraj P, Narayanan RB, Nutman TB. Impairment of tetanus-specific cellular and humoral responses following tetanus vaccination in human lymphatic filariasis. Infect Immun 2004; 72(5): 2598-604.
74. Scholzen A, Sauerwein RW. How malaria modulates memory: activation and dysregulation of B cells in Plasmodium infection. Trends Parasitol 2013; 29(5): 252-62.
75. Weiss GE, Crompton PD, Li S, et al. Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J Immunol 2009; 183(3): 2176-82.
76. Moir S, Ho J, Malaspina A, Wang W, et al. Evidence for HIVassociated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 2008; 205(8): 1797-805.
77. Sohn HW, Krueger PD, Davis RS, Pierce SK. FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling. Blood 2011; 118(24): 6332-41.
78. Ehrhardt GR, Davis RS, Hsu JT, Leu CM, Ehrhardt A, Cooper MD. The inhibitory potential of Fc receptor homolog 4 on memory B cells. Proc Natl Acad Sci USA 2003; 100(23): 13489-94.
79. Wherry EJ, Ha SJ, Kaech SM, et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 2007; 27(4): 670-84.
80. Muellenbeck MF, Ueberheide B, Amulic B, et al. Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies. J Exp Med 2013; 210(2): 389-99.
81. Bockstal V, Geurts N, Magez S. Acute Disruption of Bone Marrow B Lymphopoiesis and Apoptosis of Transitional and Marginal Zone B Cells in the Spleen following a Blood-Stage Plasmodium chabaudi Infection in Mice. J Parasitol Res 2011; 2011: 534697.
82. Bockstal V, Guirnalda P, Caljon G, et al. T. brucei infection reduces B lymphopoiesis in bone marrow and truncates compensatory splenic lymphopoiesis through transitional B-cell apoptosis. PLoS Pathogens 2011; 7(6): e1002089.
83. Acosta Rodriguez EV, Zuniga EI, Montes CL, et al. Trypanosoma cruzi infection beats the B-cell compartment favouring parasite establishment: can we strike first? Scand J Immunol 2007; 66(2-3): 137-42.
84. Corsini AC, Clayton C, Askonas BA, Ogilvie BM. Suppressor cells and loss of B-cell potential in mice infected with Trypanosoma brucei. Clin Exp Immunol 1977; 29(1): 122-31.
85. Lu LF, Rudensky A. Molecular orchestration of differentiation and function of regulatory T cells. Genes Dev 2009; 23(11): 1270-82.
86. Goldstein JD, Perol L, Zaragoza B, Baeyens A, Marodon G, Piaggio E. Role of cytokines in thymus-versus peripherally derived-regulatory T cell differentiation and function. Front Immunol 2013; 4: 155.
87. Mescher MF, Curtsinger JM, Agarwal P, et al. Signals required for programming effector and memory development by CD8+ T cells. Immunol Rev 2006; 211: 81-92.
88. Walther M, Jeffries D, Finney OC, et al. Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathogens 2009; 5(4): e1000364.
89. Minigo G, Woodberry T, Piera KA, et al. Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria. PLoS Pathogens 2009; 5(4): e1000402.
90. Couper KN, Lanthier PA, Perona-Wright G, et al. Anti-CD25 antibody-mediated depletion of effector T cell populations enhances susceptibility of mice to acute but not chronic Toxoplasma gondii infection. J Immunol 2009; 182(7): 3985-94.
91. Hall AO, Beiting DP, Tato C, et al. The cytokines interleukin 27 and interferon-gamma promote distinct Treg cell populations required to limit infection-induced pathology. Immunity 2012; 37(3): 511-23.
92. Jeong YI, Hong SH, Cho SH, Lee WJ, Lee SE. Induction of IL-10-producing CD1dhighCD5+ regulatory B cells following Babesia microti-infection. PloS one 2012; 7(10): e46553.
93. Tang H, Ming Z, Liu R, et al. Development of adult worms and granulomatous pathology are collectively regulated by T-and Bcells in mice infected with Schistosoma japonicum. PloS one 2013; 8(1): e54432.
94. Liu Y, Chen Y, Li Z, et al. Role of IL-10-producing regulatory B cells in control of cerebral malaria in Plasmodium berghei infected mice. Eur J Immunol 2013; 43(11): 2907-18.
95. Langhorne J, Ndungu FM, Sponaas AM, Marsh K. Immunity to malaria: more questions than answers. Nature Immunol 2008; 9(7): 725-32.
96. Xu H, Wipasa J, Yan H, et al. The mechanism and significance of deletion of parasite-specific CD4(+) T cells in malaria infection. J Exp Med 2002; 195(7): 881-92.
97. Wipasa J, Xu H, Stowers A, Good MF. Apoptotic deletion of Th cells specific for the 19-kDa carboxyl-terminal fragment of merozoite surface protein 1 during malaria infection. J Immunol 2001; 167(7): 3903-9.
98. Pinzon-Charry A, Woodberry T, Kienzloe V, et al. Apoptosis and dysfunction of blood dendritic cells in patients with falciparum and vivax malaria. J Exp Med 2013; 210(8): 1635-46.
99. Sponaas AM, Belyaev N, Falck-Hansen M, Potocnik A, Langhorne J. Transient deficiency of dendritic cells results in lack of a merozoite surface protein 1-specific CD4 T cell response during peak Plasmodium chabaudi blood-stage infection. Infect Immun 2012; 80(12): 4248-56.
100. Woodberry T, Minigo G, Piera KA, et al. Low-level Plasmodium falciparum blood-stage infection causes dendritic cell apoptosis and dysfunction in healthy volunteers. J Infect Dis 2012; 206(3): 333-40.
101. Wykes MN, Liu XQ, Beattie L, et al. Plasmodium strain determines dendritic cell function essential for survival from malaria. PLoS Pathogens 2007; 3(7): e96.
102. Joshi T, Rodriguez S, Perovic V, Cockburn IA, Stager S. B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections. PLoS Pathogens 2009; 5(5): e1000431.
103. Ronet C, Hauyon-La Torre Y, Revaz-Breton M, et al. Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production. J Immunol 2010; 184(2): 886-94.
104. Albareda MC, Olivera GC, De Rissio AM, Postan M. Assessment of CD8(+) T cell differentiation in Trypanosoma cruzi-infected children. Am J Trop Med Hyg 2010; 82(5): 861-4.
105. Alvarez MG, Postan M, Weatherly DB, et al. HLA Class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease. PLoS Negl Trop Dis 2008; 2(9): e288.
106. Albareda MC, Olivera GC, Laucella SA, et al. Chronic human infection with Trypanosoma cruzi drives CD4+ T cells to immune senescence. J Immunol 2009; 183(6): 4103-8.
107. Chandele A, Mukerjee P, Das G, Ahmed R, Chauhan VS. Phenotypic and functional profiling of malaria-induced CD8 and CD4 T cells during blood-stage infection with Plasmodium yoelii. Immunology 2011; 132(2): 273-86.
108. Jin HT, Anderson AC, Tan WG, et al. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci USA 2010; 107(33): 14733-8.
109. Huang B, Liu M, Huang S, et al. Expression of Tim-1 and Tim-3 in Plasmodium berghei ANKA infection. Parasitol Res 2013; 112(7): 2713-9.
110. Wu B, Huang B, Chen Y, et al. Upregulated expression of Tim-3 involved in the process of toxoplasmic encephalitis in mouse model. Parasitol Res 2013; 112(7): 2511-21.
111. Hartgers FC, Obeng BB, Kruize YC, et al. Responses to malarial antigens are altered in helminth-infected children. J Infect Dis 2009; 199(10): 1528-35.
112. Filippi CM, von Herrath MG. IL-10 and the resolution of infections. J Pathol 2008; 214(2): 224-30.
113. Clemente AM, Fadigati G, Caporale R, et al. Modulation of the immune and inflammatory responses by Plasmodium falciparum schizont extracts: role of myeloid dendritic cells in effector and regulatory functions of CD4+ lymphocytes. Infect Immun 2013; 81(5): 1842-51.
114. Schwarz T, Remer KA, Nahrendorf W, et al. T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine. PLoS Pathogens 2013; 9(6): e1003476.
115. Waghabi MC, Keramidas M, Calvet CM, et al. SB-431542, a transforming growth factor beta inhibitor, impairs Trypanosoma cruzi infection in cardiomyocytes and parasite cycle completion. Antimicrob Agents Chemother 2007; 51(8): 2905-10.
116. Fares RC, Correa-Oliveira R, de Araujo FF, et al. Identification of phenotypic markers of B cells from patients with Chagas disease. Parasite Immunol 2013; 35(7-8): 214-23.